# NIH Reporter #2P50CA254838-06

The Memorial Sloan Kettering Cancer Center SPORE in Leukemia

**Recipient:** SLOAN-KETTERING INST CAN RESEARCH

**Award Amount:** $3,031,373.00
**Ceiling:** $3,031,373.00

**Awarded:** September 17, 2026

**Identifier:** 2P50CA254838-06

Supports leukemia research focused on new targeted and immune therapies for acute myeloid leukemia, including clinical trials and studies of treatment resistance.

### Description

Funding for the MSK SPORE in Leukemia to develop targeted therapies and immunotherapeutic approaches for acute myeloid leukemia, investigate treatment response and resistance, and conduct four translational research projects supported by shared resource cores.

[View original record](https://reporter.nih.gov/search/47CiHD0bJ0u2LtDABS0zbg/project-details/11265367)